Santen | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Company Directory for Santen

Santen

Overview

Santen Pharmaceutical Co., Ltd. is a leading specialist in ophthalmic pharmaceuticals, founded in 1890 in Osaka, Japan. The company has grown to become the largest independent entity focused solely on eye care, with its products available in over 50 countries. Its journey began with the production of cold medication, later shifting focus to eye care with the launch of Daigaku Eye Drops in 1899, which remains a popular product in Japan.

The company specializes in a wide range of ophthalmic solutions, including eye drops for glaucoma and dry eye, prescription pharmaceuticals, intraocular lenses, and mydriatic products for surgical applications. With a significant market share in Japan and a presence in the global ophthalmic industry, Santen is committed to improving patient quality of life through substantial investments in research and development. It operates manufacturing plants in Japan, Finland, and China, and manages numerous subsidiaries worldwide.

Basic Information

Industry pharmaceuticals
Founded 1890
Revenue 2B
Headquarters Grand Front Osaka Tower A, Osaka, Osaka Prefecture, Japan 530-8552

Contact Details

Key Focus Areas & Initiatives

  • Ophthalmology
  • Biotechnology
  • Hardware + Software
  • Life sciences
  • Pharmaceutical manufacturing
  • Compliance
  • Retinal disorders
  • Regenerative medicine
  • Biologics development
  • Sustainability
  • Regenerative ophthalmology
  • Biotech drug delivery systems
  • Advanced ophthalmic drug formulations
  • Medical device integration
  • Healthcare innovation
  • Biologics for retinal diseases
  • Social responsibility
  • Biotech in eye care
  • Regulatory affairs in pharma
  • Medical devices
  • Ophthalmic drug manufacturing
  • Research and development
  • Ophthalmic pharmaceuticals
  • Eye health awareness
  • Drug delivery systems
  • Dry eye
  • Ophthalmic products
  • Environmental initiatives
  • Corporate governance
  • B2B
  • Ophthalmic biologics pipeline
  • Safety and quality
  • Sustainable pharma practices in eye care
  • Biologics
  • Eye care
  • Eye health solutions
  • Pharmaceuticals
  • Pharmaceutical and medicine manufacturing
  • E-commerce
  • Digital transformation in pharma
  • Vision health innovation
  • Innovative biologic therapies
  • Drug development in ophthalmology
  • Patient outcomes
  • Patient-centric
  • Eye diseases
  • Environmental load reduction in pharma
  • Digital health
  • Innovative therapies
  • Medical research
  • Global eye care market
  • Glaucoma
  • Drug delivery innovations
  • Vision impairment support programs
  • Drug formulation
  • Ophthalmology R&D
  • Digital health solutions for eye care
  • Biologics for eye diseases
  • Supply chain management
  • Global markets
  • Clinical trials transparency
  • Eye disease unmet needs
  • Supply chain
  • Regulatory compliance
  • Medical professionals
  • Sustainable growth
  • Healthcare sustainability
  • Eye health social programs
  • Medical partnerships
  • Drug delivery technology
  • Clinical research
  • Patient-centered drug development
  • Innovation
  • Sustainable pharmaceutical practices
  • Healthcare
  • Clinical trial data transparency
  • Product safety
  • Biotech collaborations in ophthalmology
  • Eye disease treatments
  • Patient-focused healthcare
  • Medical innovation
  • Biotech innovation in eye health
  • Product safety and quality
  • Services
  • Digital transformation
  • Clinical ophthalmology
  • Clinical trials
  • Risk management
  • Eye health education
  • Healthcare collaboration
  • Patient safety
  • Retail
  • Corporate social responsibility
  • Eye health
  • Patients
  • Quality assurance
  • Healthcare professionals
  • Patient satisfaction
  • Global operations
  • Vision care
  • Sustainability initiatives
  • Inclusive society
  • Product usability
  • Drug development
  • Business continuity planning
  • Environmental sustainability
  • Healthcare solutions
  • Visual impairment
  • Emergency response
  • Ethical marketing
  • Clinical testing
  • Long-term vision
  • Market access
  • Ophthalmic solutions
  • Eye care innovation
  • Transparent communications
  • Unmet medical needs
  • Global partnerships
  • High-quality products
  • Access to healthcare
  • Social innovation
  • Community engagement
  • Stakeholder engagement
  • Education
  • Manufacturing
  • Distribution
  • Transportation & logistics
  • Computer hardware
  • Computer software
  • Information technology & services
  • Medical
  • Environmental services
  • Renewables & environment
  • Hospital & health care
  • Research & development
  • Consumer internet
  • Consumers
  • Internet
  • Health, wellness & fitness
  • Logistics & supply chain
  • Health care
  • Mechanical or industrial engineering

Technologies Used

  • AI
  • Adobe CQ
  • Adobe Media Optimizer
  • Amazon AWS
  • Amazon CloudFront
  • Amazon SES
  • Data Analytics
  • DoubleClick
  • DoubleClick Conversion
  • Facebook Custom Audiences
  • Facebook Login (Connect)
  • Facebook Widget
  • Google Dynamic Remarketing
  • Google Tag Manager
  • Microsoft Azure Hosting
  • Microsoft Office 365
  • Mobile Friendly
  • Outlook
  • Rackspace MailGun
  • Remote
  • Route 53
  • Salesforce
  • Salesforce CRM Analytics
  • Sendgrid
  • reCAPTCHA

Affiliated Organizations & Regional Branches

Read more